Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 12, 2013 09:00 ET | Source: StemCells, Inc.

Stemcells, Inc. Announces First High-Dose Patient Transplanted in Phase I/II Clinical Trial in Dry Age-Related Macular Degeneration

NEWARK, Calif., Sept. 12, 2013 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) today announced dosing of the first high-dose patient in the Company's Phase I/II clinical trial in dry age-related...
September 09, 2013 09:00 ET | Source: StemCells, Inc.

StemCells, Inc. Publishes Comprehensive Review of Results From HuCNS-SC Clinical Trials

NEWARK, Calif., Sept. 9, 2013 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) today announced the publication of a comprehensive overview describing the therapeutic potential and results from early...
August 07, 2013 16:05 ET | Source: StemCells, Inc.

StemCells, Inc. Reports Second Quarter 2013 Financial Results and Provides Business Update

NEWARK, Calif., Aug. 7, 2013 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM), a leading stem cell company developing and commercializing novel cell-based therapeutics and tools for use in stem...
August 05, 2013 09:00 ET | Source: StemCells, Inc.

StemCells, Inc. Announces Webcast to Discuss Second Quarter 2013 Financial Results and Business Update

NEWARK, Calif., Aug. 5, 2013 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM), a leading stem cell company developing and commercializing novel cell-based therapeutics and tools for use in stem...
August 02, 2013 09:00 ET | Source: StemCells, Inc.

StemCells, Inc. Presents Two-Year Pelizaeus-Merzbacher Disease (PMD) Data Suggesting Departure From Natural History of the Disease

NEWARK, Calif., Aug. 2, 2013 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) today presented data which show that two years after transplantation of the Company's proprietary HuCNS-SC® cells...
July 30, 2013 09:00 ET | Source: StemCells, Inc.

StemCells, Inc. Launches Alzheimer's Disease Program Supported by California Institute for Regenerative Medicine

NEWARK, Calif., July 30, 2013 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) today announced that it has formally launched its Alzheimer's disease program, which is being supported by the...
July 01, 2013 09:00 ET | Source: StemCells, Inc.

StemCells, Inc. Added to Russell Microcap Index

NEWARK, Calif., July 1, 2013 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) today announced its addition to the Russell Microcap Index following Russell Investments' reconstitution of its...
June 10, 2013 09:00 ET | Source: StemCells, Inc.

StemCells, Inc. Strengthens Product Development Team and Appoints Executive to Focus on Scientific and Strategic Alliances

NEWARK, Calif., June 10, 2013 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) today announced key hires to strengthen its product development capabilities and announced the creation of a new...
June 04, 2013 09:00 ET | Source: StemCells, Inc.

StemCells, Inc. Secures $30 Million Financing Commitment From Lincoln Park Capital

NEWARK, Calif., June 4, 2013 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM), a leading stem cell company developing and commercializing novel cell-based therapeutics and tools for use in stem...
June 03, 2013 09:00 ET | Source: StemCells, Inc.

StemCells, Inc.'s Spinal Cord Injury Trial Approved by Health Canada

NEWARK, Calif., June 3, 2013 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) today announced that Health Canada has authorized the Company to expand its Phase I/II clinical trial for chronic spinal...